Paper20173543
T1/T2 matching to differentiate tumor growth from radiation effects after stereotactic radiosurgery.
Kano H and 5 others. Neurosurgery, 2010. Cited by 155 papers, by iCite.
Cite this record
ConductScience Library. T1/T2 matching to differentiate tumor growth from radiation effects after stereotactic radiosurgery. Papers, record 20173543. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/20173543
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- T1/T2 matching to differentiate tumor growth from radiation effects after stereotactic radiosurgery.
- PubMed
Topics15
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Neoplasm Recurrence, Local | Major topic |
| Neurosurgical Procedures | Major topic |
| Radiosurgery | Major topic |
| Adult | |
| Aged | |
| Aged, 80 and over | |
| Brain Neoplasms | |
| Disease Progression | |
| Female | |
| Humans | |
| Magnetic Resonance Imaging | |
| Male | |
| Middle Aged | |
| Statistics, Nonparametric | |
| Young Adult |
Source PubMed
Cited by84
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 155 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42663779 | Pathology-validated structural and physiologic habitat imaging for differentiating radiation necrosis from tumor recurrence in brain metastases. | J Neurooncol | 2026 | https://conductscience.org/library/papers/42663779 | PubMed |
| 42585297 | LINAC-based single-isocenter stereotactic radiotherapy for multiple brain metastases. | J Radiat Res | 2026 | https://conductscience.org/library/papers/42585297 | PubMed |
| 42484747 | The threefold value of surgery in previously irradiated brain metastases. | J Neurooncol | 2026 | https://conductscience.org/library/papers/42484747 | PubMed |
| 42029788 | Long-term safety and efficacy of staged stereotactic radiosurgery with Ommaya reservoir aspiration for large cystic brain metastases. | J Neurooncol | 2026 | https://conductscience.org/library/papers/42029788 | PubMed |
| 41949945 | Optimising Brain Metastases Management in Resource-Limited Settings: Experience with Hypofractionated Stereotactic Radiotherapy at the Salah Azaiez Institute. | Tunis Med | 2025 | https://conductscience.org/library/papers/41949945 | PubMed |
| 41266380 | MU-Glioma Post: A comprehensive dataset of automated MR multi-sequence segmentation and clinical features. | Sci Data | 2025 | https://conductscience.org/library/papers/41266380 | PubMed |
| 40913628 | FLAIR extending beyond a quadrant (FEQ) of the cerebrum as a qualitative imaging biomarker: a conceptual proposition and proof-of-principle. | Clin Exp Metastasis | 2025 | https://conductscience.org/library/papers/40913628 | PubMed |
| 40839242 | Gamma knife radiosurgery for breast cancer brain metastasis: survival outcomes, prognotic factors, and the role of repeat treatment. | J Neurooncol | 2025 | https://conductscience.org/library/papers/40839242 | PubMed |
| 40702846 | The Black Hole of Immune Checkpoint Blocking Therapy for Gastric Cancer: Hyperprogressive Disease. | Cancer Sci | 2025 | https://conductscience.org/library/papers/40702846 | PubMed |
| 40560014 | Applications of Advanced Imaging for Radiotherapy Planning and Response Assessment in the Central Nervous System. | Tomography | 2025 | https://conductscience.org/library/papers/40560014 | PubMed |
| 39961102 | Re-irradiation followed by resection for recurrent brain metastases after initial stereotactic radiosurgery: illustrative cases. | J Neurosurg Case Lessons | 2025 | https://conductscience.org/library/papers/39961102 | PubMed |
| 39677170 | Magnetic Resonance Imaging Assessment of Morphological Changes and Molecular Behavior to Evaluate Treatment Response of Brain Metastatic Lesions After Stereotactic Radiosurgery. | Cureus | 2024 | https://conductscience.org/library/papers/39677170 | PubMed |
| 39193387 | Single versus multiple fraction stereotactic radiosurgery for medium-sized brain metastases (4-14 cc in volume): reducing or fractionating the radiosurgery dose? | Front Oncol | 2024 | https://conductscience.org/library/papers/39193387 | PubMed |
| 39107039 | Gadolinium-Enhanced T2 FLAIR Is an Imaging Biomarker of Radiation Necrosis and Tumor Progression in Patients with Brain Metastases. | AJNR Am J Neuroradiol | 2025 | https://conductscience.org/library/papers/39107039 | PubMed |
| 39026289 | Assessment of imaging risks for recurrence after stereotactic radiosurgery for brain metastases (IRRaS-BM). | BMC Cancer | 2024 | https://conductscience.org/library/papers/39026289 | PubMed |
| 38730695 | Long-Term Results of Stereotactic Radiotherapy in Patients with at Least 10 Brain Metastases at Diagnosis. | Cancers (Basel) | 2024 | https://conductscience.org/library/papers/38730695 | PubMed |
| 38707120 | Proposal of an Alternative Near-Minimum Isodose Surface DV-0.01 cc Equally Minimizing Gross Tumor Volume Below the Relevant Dose as the Basis for Dose Prescription and Evaluation of Stereotactic Radiosurgery for Brain Metastases. | Cureus | 2024 | https://conductscience.org/library/papers/38707120 | PubMed |
| 38630386 | Improved outcomes for triple negative breast cancer brain metastases patients after stereotactic radiosurgery and new systemic approaches. | J Neurooncol | 2024 | https://conductscience.org/library/papers/38630386 | PubMed |
| 38437665 | The dilemma of radiation necrosis from diagnosis to treatment in the management of brain metastases. | Neuro Oncol | 2024 | https://conductscience.org/library/papers/38437665 | PubMed |
| 38356008 | Methyl-11C-L-methionine positron emission tomography for radiotherapy planning for recurrent malignant glioma. | Ann Nucl Med | 2024 | https://conductscience.org/library/papers/38356008 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/20173543
GET https://conductscience.org/api/papers/v1/20173543/cited_by?page=2